Translational Safety Endpoints in Nonclinical Studies
Time: 11:15 am
day: Day One
Details:
- Determine key design considerations for AAV nonclinical studies
- Discuss key endpoints in ocular and CNS gene therapy
- Evaluate translational review of data for clinical trials
